M&A - The trials and tribulations
Former Schering & Plough CEO speaks out about the pharmaceutical Industry. Where they went wrong and the solutions, which lead to the successful sale...
read more

_____________________________

Pharminox appoints Iain Ross as Chairman
Pharminox Limited, ("Pharminox" or "the Company") the UK-based cancer drug discovery and development company, today announced that it has appointed Iain Ross as Non-executive Chairman...
read more

_____________________________

ICON Central Laboratories Expands its European Facility to Meet Growing Demand
ICON plc, NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has expanded its European Central Laboratory, located in South County Business Park, Dublin...
read more

_____________________________

Dr. Christian Müller to be appointed new CFO of Carl Zeiss Meditec
Dr. Christian Müller (42) is to be appointed as a new member of the Management Board and Chief Financial Officer of Carl Zeiss Meditec AG with effect from 15 December 2009...
read more

_____________________________

Brecon strengthens board line-up
Brecon Pharmaceuticals, the leading supplier of commercial packaging and clinical trials supplies services for the pharmaceutical and healthcare sectors, has announced the appointment of Peter Belden as managing director...
read more

_____________________________

>>Read more news stories                                                                   

»Adverse Drug Events - Reporting & Regulatory Requirements
Date: 1 - 2 March 2010
Location: Berlin, Germany
View Website

________
 
»The Drug Development Process - From Discovery to Commercialisation
Date: 3 - 5 March 2010
Location: Berlin, Germany
View Website

________

»Quality by Design for Analytical Methods: A Revolution in Method Lifecycle Management?
Date: 4 March 2010
Location: London, UK
View Website

________

»ADMET Europe
Date: 8 - 9 April 2010
Location: Munich, Germany
View Website

________

»MedChem Europe
Date: 8 - 9 April 2010
Location: Munich, Germany
View Website

________

»SBS 16th Annual Conference & Exhibition
Date: 11 - 15 April 2010
Location: Phoenix, Arizona, USA
View Website


 
 

Applying statistical inference in genomics with evidence-based pathways: Towards elucidating new functional correlations of biomarkers
Peter Ghazal, Professor of Molecular Genetics and Biomedicine, University of Edinburgh and Head of Division of Pathway Medicine and Associate Director of Centre for Systems Biology, Edinburgh, Al Ivens, Head of Data Analysis, Fios Genomics Ltd and Thorsten Forster, Statistical Bioinformatician, Division of Pathway Medicine, University of Edinburgh

In conventional pharmacogenomic studies, genetic polymorphisms (including single nucleotide and copy number variations) are elucidated from case-control distribution of individuals usually representing ethnicity, severity of disease, and positive or negative response to treatment...

Read article in full

_________________________________

Cellular Imaging & Analysis Business Unit
Mark Collins from Thermo Fisher Scientific, who provide analytical instruments, laboratory equipment, software, services, consumables and reagents, talks to us about current developments and future changes...
Read more

________

________

Protein PEGylation: An overview of chemistry and process considerations
Vinod Babu Damodaran, Senior PhD student under Professor Fee and Professor Conan Fee, Professor of Chemical Engineering and Co-Director of the Biomolecular Interactions Centre, University of Canterbury, NZ

Innovative drug delivery technologies are key components of drug development, with commercial and intellectual values. PEGylation is an excellent example of a delivery system that has scientific and multi- billion dollar commercial importance due to the remarkable improvement in the circulatory half lives of therapeutics, especially for proteins and peptides but even for small molecule pharmaceuticals...

Read article in full

_________________________________

Segregation of molecular mechanisms of genotoxicity and carcinogenicity across human, yeast and Salmonella species
Willem Schoonen, Walter Westerink and Jean Horbach, Department of Toxicology and Drug Disposition, MSD, The Netherlands

Screening assays for in vitro toxicity are the way to reduce the attrition rates in the preclinical development of new drugs...

Read article in full

_______________________________

Cancer-secreted microRNAs: Travelers, Messengers, and Blood-borne Biomarkers
Dr John Rossi, Professor and Chair, Division of Molecular Biology and Dean, Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope and Emily Wang, Assistant Professor, Deptartment of Cancer Biology/Division of Tumour Cell Biology, Beckman Research Institute of City of Hope 

Since the first discovery of microRNA (miRNA) from C. elegans in 19931 studies of this new class of regulatory small RNA have grown rapidly and entered a new era, where they now serve as potential biomarkers and therapeutic targets in human diseases, such as cancers...

Read article in full

_______________________________ 

Cancer biology where do we go next?
Dr Anthony Davis, Director of High Content Research Facility, Department of Clinical Medicine, Dr Anthony McElligott, Research Scientist, Institute of Molecular Medicine, Dr Graham Pidgeon, PhD., Senior Lecturer in Surgery/Molecular Oncology, Institute of
Molecular Medicine, Dr Anthony Ryan, Research Scientist, Institute of Molecular Medicine, Trinity College Dublin and Dr Ruth Foley, Prostate Cancer Research Group

The World Cancer Report (2008) predicts a 50% worldwide increase in cancer incidence by 2030, predicting 75 million people living within a five year diagnosis of cancer¹...

Read article in full

_____________________________